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Abstract. Classification of a continuous risk score into risk levels is common. 
However, while the absolute risk score is essential, it is arguably unethical to label 
anyone at ‘high, moderate or low risk’ of a serious event, simply because 
management based on a single criterion (e.g. avoiding the target condition) has 
been determined to be effective or cost-effective at a population level. Legally, 
mono-criterial risk labeling can inhibit the obtaining of a fully-informed, 
preference-based consent, since multiple considerations (various benefits and 
harms) matter to most individuals, not only the single criterion that is the basis of 
the provided risk category. These ethical and legal challenges can be met by 
preference-sensitive multi-criteria decision support tools. In this future vision 
paper, we demonstrate, at a conceptual proof-of-method level, how such decision 
support can and should be developed without reference to risk-level 
classifications. The statin decision is used as illustration, without any empirical 
claims. 
Keywords. risk thresholds, risk classifications, person-centred decision support, 
Multi-Criteria Decision Analysis 
1. Introduction 
In their recent investigation of General Practitioner (GP)s statin prescribing for the 
primary prevention of Cardiac Vascular Disease (CVD), Robinson et al. found no 
upward ‘blip’ at either of the guideline thresholds placed on the New Zealand-adjusted 
Framingham CVD risk score [1]. However, in person-centred care, the case for using 
an absolute risk score in decision making, rather than managing on the basis of a 
threshold-based segmentation of the risk scale (e.g. into high, moderate or low risk), 
cannot rest on whether or not clinicians actually practice this way. To give their 
informed and preference-based consent to any test or treatment, the person must be 
informed about the harms and benefits of all the relevant options, with the magnitudes 
of those harms and benefits being assessed on the basis of their personal importance 
weights at or near the point of decision. While this requirement is rarely fully met 
today (except in surgery) it will be a prominent feature of the future we envisage and 
address in this vision paper. A key implication is that it will not be acceptable to focus 
on the single outcome proposed as the main criterion, e.g. CVD in the above case, 
Fracture in the bone health case, Breast cancer in an oncology case.  The decision 
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process must address the other criteria -considerations and things that matter to the 
person - equally as seriously and equally as analytically. When combined with the 
requirement for the individual to be able to weight those criteria explicitly and 
transparently, one is driven towards some form of multi-criteria analysis personalised 
decision support tool [2]. The need for a single-criterion, threshold-based guideline, 
based on average patients, becomes moot. 
 
We can find no analytical basis for particular thresholds (e.g. 10%, 15%, 20%) and 
resulting risk characterisations – for most conditions - other than population level 
effectiveness and cost-effectiveness analyses. While appropriate at the policy level, this 
makes them inappropriate in person-centred care. It is unethical to tell someone they 
are at ‘high, or moderate, or low risk’ of a serious event simply because the standard 
management for the relevant risk range has, or has not, been determined to be cost-
effective – or simply effective by some single criterion - at a population level. The 
Frax®-based guidelines in relation to primary prevention of fractures [3,4] and 
screening guidelines for most cancers are guilty of the same offence. From a wider 
perspective, risk classifications are just another way of clustering individuals to 
simplify guidelines and service provision. As a result, average group preferences are 
often used, inappropriately, in preference-sensitive individual decisions.  
 
The argument against segmentations of risk measures is even stronger when it 
extends to basing management decisions solely on the individual’s relative risk in a 
statistical distribution for a population. Hypertension provides a highly relevant 
example, where the typical risk classification includes defining the disease on the basis 
of systolic and diastolic blood pressure levels above 130/90 or 140/90. A disease called 
osteoporosis exists if (and only if) an individual’s bone mineral density is 2.5 standard 
deviations below a group norm (that for a young white US female). Diabetes is a 
further example. All these statistical definitions infringe the individual’s right to make 
a decision based on their individual absolute risk, as well as possibly being a major 
source of over diagnosis and overtreatment [5]. 
 
The aim of this paper is limited to providing proof of method, at a conceptual 
level, that decision support tools based on the technique of Multi-Criteria Decision 
Analysis (MCDA) can claim to meet both the ethical requirements for person-centred 
care and the legal requirements for consent. This is done - necessarily - without 
reference to any thresholds or classifications imposed on continuous risk measures. The 
example of a statin decision support tool is provided, but purely as illustration. It has 
no empirical claims to be a properly developed and validated tool.  
2. Methods 
 
The type of decision support tool we envisage becoming a familiar feature of the e-
health future - because of their ability to meet these twin requirements - are based on 
MCDA. As noted in the recent ISPOR Task Force reports, MCDA methods are widely 
used in public-sector and private-sector decisions on transport, immigration, education, 
investment, environment, energy, and defence, and but the health care sector has been 
relatively slow to apply them [6,7]. 
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The type of MCDA most compatible with ethical person-centred decision making 
and most able to ensure informed and preference-based consent is the value-based, 
compensatory model. This takes the form of a ‘weighted-sum’ model, which multiplies 
the personalised numerical ratings for the performance of each option on each criterion 
by the relative weight assigned to the criterion by the person, and then sums these 
weighted scores to get an overall preference-sensitive score for each option.  
 
The performance ratings for all options on all criteria must be on the same 
continuous 0-1 (0 to 100%) scale and be personalised to the absolute risk of the 
individual concerned. Any segmented classification of an absolute risk for any criterion 
will undermine cross-criterial comparability and hence the coherence of the analysis. 
 
3. Result 
The illustration is of a multi-criterial personalised decision support tool for the statin 
decision: Should I go, or not go, to my general practitioner to discuss taking statins?   
It shows how an overall opinion can be obtained from such a tool without any 
threshold-based risk classification and indeed that the tool requires the unclassified 
absolute risks to be input wherever these are relevant.   
The statin decision support tool, built within the Annalisa implementation of 
MCDA [2], involves the person: 
1. completing an online instrument to obtain an estimate of their personalised 
absolute risks of All-Cause and Cardiovascular Mortality in the next ten years 
2. self-assessing their blood pressure and total cholesterol level, which are the two 
inputs required, along with age, sex and smoking status, to complete the 
online EuroSCORE-based instrument 
3. self-rating the treatment burden of statins 
4. assigning relative importance weights to four criteria (two 10 year mortalities, 
statin side effects and statin burden). 
All these inputs are on continuous scales, albeit with different granularity, but 
without any threshold cut-offs.  The tool is best understood by engaging with it. It is 
accessible at https://goo.gl/H7P51r. 
 
The tool is derived directly from Støvring et al. [8] and purports only to translate 
the data in that study into multi-criteria decision support format as an illustrative proof 
of method. It adds two of the other criteria that would be needed in personalised tools - 
treatment side effects and treatment burden - and others maybe added in a fully-
developed tool. We reiterate, its purpose here is purely illustrative, not empirical. 
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4. Discussion 
Publicly accessible, multi-criteria analysis-based personal decision support tools are 
widely available to consumers in many areas of life. Which (UK), Tænk (Denmark), 
and Choice (Australia) are familiar examples of comparison services that support the 
decision as to which fridge, which vacation package, or which insurance package to 
obtain. While health decisions are undoubtedly more important, it is fallacious to 
assume that a different decision support structure is necessarily required here [9]. 
Deeper thinking about what goes into that structure, especially the criterion weightings 
and performance ratings, may be the route to higher quality ‘tough’ decisions. 
 
A decision support tool (DST) is distinguished from an ‘Information Support Tool’ 
by (i) the structuring of the information it presents in decision-relevant form, and (ii) 
the elicitation of the person’s preferences (criterion weights) at or near the point of 
decision, and (iii) the presentation of an algorithmic synthesis of the information and 
elicited preferences as scores for all the options included in the aided analysis. Some 
‘patient decision aids’ (Option Grids, Mayo Cards) meet the first requirement, but do 
not satisfy the other two. They are also usually designed solely for use within clinical 
encounters and are available only through a health provider. 
 
In conclusion, risk thresholds and classifications based on single criterion 
effectiveness and/or cost-effectiveness are inappropriate in person-centred care, even if 
possibly useful in policy-making and research. Personalised multi-criterial decision 
support tools avoid threshold-based risk classification and thereby facilitate the ethical 
and legal practice that will be demanded in the coming digital paradigm [10]. 
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